Prolactinoma
📧 Sign up to get email alerts when something new happens for Prolactinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Exercise Capacity and Physical Activity Level in Prolactinoma Patients
A completed clinical trial update examining exercise capacity and physical activity levels in patients with prolactinoma. The study status i…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated ropinirole, a non-ergoline dopamine agonist, for hyperprolactinemia and prolactinoma. The study is comp…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: PRolaCT - Three Prolactinoma RCTs [Phase 4]
Phase 4 clinical trial update for three prolactinoma trials (PRolaCT) sponsored by Leiden University Medical Center.
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Clomiphene in Males With Prolactinomas and Persistent Hypogonadism [Phase 2]
A Phase 2 trial evaluating clomiphene in men with prolactinomas and persistent hypogonadism has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-01Clinical Trial Update: Insulin Resistance in Women With Prolactinoma
This completed clinical trial, sponsored by Universidade Federal do Rio de Janeiro, evaluated insulin resistance in women with prolactinoma;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.